Trexquant Investment 13F: Adds $18M to BTSG Stake

Trexquant Investment Grows Position in BrightSpring Health Services

Trexquant Investment lifted its stake in BrightSpring Health Services, Inc. (NasdaqGS: BTSG) by 130.2% during the period, purchasing 260,132 more shares. The quarterly Form 13F filing submitted to the U.S. Securities and Exchange Commission shows that the fund owned 459,885 shares at the close of the period. That expanded holding carried a reported value of approximately $32.1 million. Because 13F filings look backward at portfolio choices made months ago, this snapshot may not match the fund's current holdings today.

Inside the Portfolio Adjustment for BTSG Shares

Before this increase, the firm held 199,753 shares of the healthcare provider. Adding 260,132 shares more than doubled the size of the investment in a single quarter. This step follows earlier portfolio moves by the same fund, which recently trimmed its position in AbbVie while initiating new stakes in Canadian National Railway and Church & Dwight.

BrightSpring Health Stock Trades Near Recent Highs

The shares recently changed hands around $69.74, sitting well above their 52-week low of $26.28 and near the top end of their yearly range of $73.75. The company operates with a trailing price-to-earnings ratio of 49.9 and a forward price-to-earnings ratio of 24.5. Its fifty-day moving average sits at $62.86, while the longer-term two-hundred-day moving average rests at $51.33.

Recent Earnings and Financial Results

For its recent reporting period, BrightSpring Health reported $1.12 in earnings per share alongside total revenue of $14.37 billion. The company generated a net profit margin of 2.5% and a return on equity of 13.0%. Revenue grew 23.0% compared to the prior period. Shareholders can look ahead to the next earnings update scheduled for October 30, 2026.

Wall Street Analysts Update Price Targets

Wall Street firms have kept a positive outlook on the healthcare provider as shares climbed. On August 13, 2026, BTIG reiterated its buy rating with a $90.00 price target, matching an earlier note from August 3, 2026. Morgan Stanley maintained its overweight rating on July 14, 2026, and lifted its target to $80.00 from $71.00. Keybanc also maintained an overweight rating on July 14, 2026, raising its target to $80.00 from $60.00. Wells Fargo maintained an overweight rating on July 13, 2026, lifting its target to $78.00 from $61.00. Guggenheim initiated coverage with a buy rating and an $81.00 target on July 13, 2026. Raymond James initiated an outperform rating with an $80.00 target on July 10, 2026. UBS maintained a buy rating while lifting its target to $85.00 from $63.00 on July 8, 2026.

Inside the Provider Services Platform

Headquartered in Louisville, Kentucky, BrightSpring Health Services operates a home and community-based healthcare platform across the United States. The enterprise functions through two core divisions: Pharmacy Solutions and Provider Services. Its network delivers clinical care, supportive living, and medication services to Medicare, Medicaid, and insured populations. The business employs roughly 23,500 people and provides specialized pharmacy offerings alongside rehabilitation therapy.

Looking Ahead at Institutional Filings

Institutional reports give a window into how major quantitative managers adjust their sector exposure over time. Market participants will watch upcoming regulatory disclosures to see if Trexquant continues to build out its healthcare holdings or shifts capital elsewhere as the year progresses.